Acute primary infection with cytomegalovirus (CMV) in kidney transplant recipients results in the appearance of a phenotypically aberrant CD8+ T cell population

Microbiology and Immunology

Volumn 44, Issue 12, 2000, Pages 1011-1017

  Van Dam, Joanne G ^a   Damoiseaux, Jan G M C ^b   Christiaans, Maarten H L ^b   Bruggeman, Cathrien A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anergy; CD8 T cells; Cytomegalovirus; Transplantation

Indexed keywords

HLA DR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CELL FUNCTION; CLONAL ANERGY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; KIDNEY TRANSPLANTATION; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

EID: 0034535647     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2000.tb02597.x     Document Type: Article

References (25)

1. Down-regulation of CD8 beta-chain in response to an altered peptide ligand enables developing thymocytes to escape negative selection
2. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens
3. Serial flow cytometric analysis of T-cell surface markers can be useful in differential diagnosis of renal allograft dysfunction
4. Cytotoxic T-cell precursors with low-level CD8 in the diabetes-prone biobreeding rat: Implications for generation of an autoimmune T-cell repertoire
5. Anergic CD8 + T cells can persist and function in vivo
6. Pathogenicity: Animal models
7. Infection of laboratory rats with a new cytomegalo-like virus
8. Biology of rat cytomegalovirus infection
9. M144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection
10. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo
11. Cytomegalovirus evasion of natural killer cell responses
12. Recall response to cytomegalovirus in allograft recipients: Mobilization of CD57+, CD28+ cells before expansion of CD57 +, CD28- cells within the CD8 + T lymphocyte compartment
13. Cytomegaloviral control of MHC class I function in the mouse
14. CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: Expansion of an uncommon CD8+ CD57- subset and its progressive replacement by CD8+ CD57+ T cells
15. Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma
16. Immunologic parameters as predictive factors of cytomegalovirus desease in renal allograft recipients
17. Viral strategies of immune evasion
18. Animal models of human immunopathological disease syndromes induced by cytomegalovirus infection
19. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction
20. Models of T cell anergy: Is there a common molecular mechanism?
21. An animal model for therapeutic intervention studies of cmv infection in the immunocompromised host
22. Infection with rat cytomegalovirus (CMV) in the immunocompromised host is associated with the appearance of a T cell population with reduced CD8 and T cell receptor (TCR) expression
23. Recovery from cytomegalovirus infection is associated with activation of peripheral blood lymphocytes
24. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood
25. Viruses use stealth technology to escape from the host immune system